Expression of vascular endothelial growth factor (VEGF) in tumor cells is mediated by the soluble form of CD276, suggesting that the combination of anti-CD276 and anti-VEGF drugs is a potential therapeutic approach [24]. This evidence concerns the gene VEGFA and neoplasm.